Recall: D-0340-2026

Class II - Potentially Harmful

Class IIClassification

2026-02-09Initiated

OngoingStatus

Meitheal Pharmaceuticals, IncFirm

Product

Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.

Reason

Defective Delivery System: Missing or duplicated needles within the injection kit

Distribution

U.S. Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.